Abstract:Background: 5-hydroxytryptophan (5-HTP), the direct biosynthetic precursor of the neurotransmitter 5-hydroxytryptamine, has been shown to have unique efficacy in the treatment of a variety of disorders, including depression, insomnia, and chronic headaches, and is one of the most commercially valuable amino acid derivatives. However, microbial fermentation for 5-HTP production continues to face many challenges, including low titer/yield and the presence of the intermediate L-tryptophan (L-Trp), owing to the complexity and low activity of heterologous expression in prokaryotes. Therefore, there is a need to construct an efficient microbial cell factory for 5-HTP production. Results: We describe the systematic modular engineering of wild-type Escherichia coli for the efficient fermentation of 5-HTP from glucose. First, a xylose-induced T7 RNA polymerase-PT7 promoter system was constructed to ensure the efficient expression of each key heterologous pathway in E. coli. Next, a new tryptophan hydroxylase mutant was used to construct an efficient tryptophan hydroxylation module, and the cofactor tetrahydrobiopterin synthesis and regeneration pathway was expressed in combination. The L-Trp synthesis module was constructed by modifying the key metabolic nodes of tryptophan biosynthesis, and the heterologous synthesis of 5-HTP was achieved. Finally, the NAD(P)H regeneration module was constructed by the moderate expression of the heterologous GDHesi pathway, which successfully reduced the surplus of the intermediate L-Trp. The final engineered strain HTP11 was able to produce 8.58 g/L 5-HTP in a 5-L bioreactor with a yield of 0.095 g/g glucose and a maximum real-time productivity of 0.48 g/L/h, the highest values reported by microbial fermentation. Conclusion: In this study, we demonstrate the successful design of a cell factory for high-level 5-HTP production, combined with simple processes that have potential for use in industrial applications in the future. Thus, this study provides a reference for the production of high-value amino acid derivatives using a systematic modular engineering strategy and a basis for an efficient engineered strain development of 5-HTP high-value derivatives.

Metabolic engineering of Escherichia coli for N-methylserotonin biosynthesis

Metabolic Engineering of Escherichia Coli W3110 for the Production of L-Methionine

Combining protein and metabolic engineering strategies for biosynthesis of melatonin in Escherichia coli

Metabolic engineering of Escherichia coli for efficient production of L-5-hydroxytryptophan from glucose

Metabolic Engineering of Escherichia coli for Production of 2,5-Dimethylpyrazine

Engineering the L-tryptophan metabolism for efficient de novo biosynthesis of tryptophol in Saccharomyces cerevisiae

Systems engineering of Escherichia coli for high-level shikimate production

Biosynthesis of melatonin from L-tryptophan by an engineered microbial cell factory

Enhancing tryptophan production by balancing precursors in Escherichia coli

"In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli"

Metabolic Pathway Engineering for High-Level Production of 5-Hydroxytryptophan in Escherichia Coli.

Multivariate modular metabolic engineering for enhanced l-methionine biosynthesis in Escherichia coli

Metabolic Engineering and Fermentation Process Strategies for L-Tryptophan Production by Escherichia coli

Metabolic engineering of Saccharomyces cerevisiae for chelerythrine biosynthesis

Metabolic Engineering of Pichia pastoris for Overproduction of Cis-trans nepetalactol

Metabolic Engineering of Escherichia Coli for the Production of L-Homoserine

Metabolic engineering of Escherichia coli for seleno-methylselenocysteine production

Combinatorial Metabolic Engineering of <i>Escherichia coli</i> for Enhanced L-Cysteine Production: Insights into Crucial Regulatory Modes and Optimization of Carbon-Sulfur Metabolism and Cofactor Availability

Metabolic engineering for the biosynthesis of bis-indolylquinone terrequinone A in Escherichia coli from L-tryptophan and prenol

Bioengineering of Escherichia coli Nissle 1917 for Production and Excretion of Spermidine, a Key Metabolite in Human Health

De Novo Synthesis of 1-Phenethylisoquinoline in Engineered Escherichia Coli